Vascular Ultrasound Versus Intravascular Ultrasound for Diagnosing Iliac Vein Obstruction (USG-DIVO)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02240914
Recruitment Status : Unknown
Verified September 2014 by Fabio H Rossi, Instituto Dante Pazzanese de Cardiologia. Recruitment status was: Recruiting
First Posted : September 16, 2014
Last Update Posted : September 16, 2014
Fabio H Rossi
Instituto Dante Pazzanese de Cardiologia
Fundação de Amparo à Pesquisa do Estado de São Paulo
Information provided by (Responsible Party):
Fabio H Rossi, Instituto Dante Pazzanese de Cardiologia
Determine the sensitivity, specificity and accuracy of vascular ultrasound, using direct and indirect ultrasonographic signs, in the obstructive diseases of iliac venous segment, in patients with advanced chronic venous insufficiency (CEAP 3-6), considering the intravascular ultrasound (IVUS) as the gold standard for this diagnosis.
Develop an algorithm for noninvasive ultrasound investigation of obstructive lesions in the iliac segment in patients with advanced chronic venous insufficiency (CEAP 3-6).
A composite of direct and indirect ultrasonographic signs as a measure of iliac vein stenosis [ Time Frame: within 15 days ]
• 50 patients with Clinical-Etiologic-Anatomic-Pathophysiologic (CEAP) classification C3-6 undergoing iliac and common femoral vascular ultrasound imaging with intention to detect significative iliac vein obstructions ( > 50%) and this results will be compared with the gold standard method - IVUS. Primary Endpoints: venous imaging in B- mode, volume flow and expiratory velocity in femoral vein, and the velocity relation before and through the stenosis provided by vascular ultrasound will be analyzed. Venous IVUS will provide measurements of minimum and maximum diameter reduction due to iliofemoral venous obstruction/compression; cross-sectional area reduction will also be measured.
The percentage of significant stenosis detected at various thresholds [ < 50%, 50-80%,> 80%] with each method will be compared in a pair-wise fashion. This will be done with descriptive statistics of the detection rates for each method, and the rate of discordance between the two.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 80 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Subjects with iliac compression disease CEAP classification 3-6.
Advanced Chronic Venous Insufficiency (CEAP 3-6) submitted to clinical treatment for at least 1 year with no response.
Subject must be > 18 and < 80 years of age
Willing to participate in and able to understand, read and sign the informed consent document before the planned procedure
On duplex ultrasound: patent common femoral vein, and patent deep femoral vein, and/or femoral vein of the study leg
Subject cannot or will not provide written informed consent
Previous venous stent implantation involving the study leg or inferior vena cava
Previous venovenous bypass surgery involving the study leg
Known reaction or sensitivity to iodinated contrast that cannot be managed with premedication
Subjects who are pregnant (women of childbearing potential must have a negative pregnancy test within 7 days prior to enrollment
Acute deep venous thrombosis involving either leg
Known history of chronic total occlusion of the common femoral vein of the study leg.
Known history of thrombophilia (e.g., protein C or S deficiency, anti-thrombin III deficiency, presence of lupus anticoagulant, etc.)
Venous compression caused by tumor encasement
Venous outflow obstruction caused by tumor thrombus
Life expectancy of less than 6 months
Lower Extremity Arterial Insufficiency
Elevated baseline blood creatinine (value greater than the upper limit of the normal range)
Any concurrent disease or condition that, in the opinion of the Investigator, would make the subject unsuitable for participation in the study; examples include but are not limited to the inability to lie supine for the index procedure (e.g., severe congestive heart failure), thrombocytopenia or other hematological disorders associated with an unacceptable risk of bleeding, implanted orthopedic hardware that precludes proper imaging, etc.